Aug 12, 2015
1:12
For every 12 shares held, investors received 1.
The split itself did not change the total investment value.
Champions Oncology, Inc. (GETTEX:2I3) operates in the Biotechnology industry.
Champions Oncology, Inc. company overviewChampions Oncology, Inc.'s most recent stock split was on August 12, 2015. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
Champions Oncology, Inc. (GETTEX:2I3) has split its stock 2 times: a 1-for-100 reverse split on November 1, 1991 and a 1-for-12 reverse split on August 12, 2015.
Champions Oncology, Inc. has split its stock 2 times. This history records 2 reverse splits between November 1, 1991 and August 12, 2015.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Champions Oncology, Inc.'s 1-for-12 reverse split on August 12, 2015, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Champions Oncology, Inc. has not announced a new split in our records. Its most recent split was on August 12, 2015, 11 years ago. Companies announce splits in advance, and any new GETTEX:2I3 split will appear on this page.